3Schellekens GA, Visser H, De Jong BA, et al. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide [J]. Arthritis Rheum, 2000,43( 1 ) : 155-163.
5Cader MZ,Filer AD, Buckley CD, et al. The relationship between the presence of anti-cyclic citrullinated peptide antibodies and clinical phenotype in very early rheumatoid arthritis [ J]. BMC Musculoskelet Disord, 2010,11(1) :187.
6Ueda-Hayakawa I, Hasegawa M, Kumada S, et al. Usefulness of anti-cyclic citrullinated peptide antibody and rheumatoid factor to detect rheumatoid arthritis in patients with systemic sclerosis [ J ]. Rheumatology (Oxford), 2010,49( 11 ) :2135-2139.
二级参考文献14
1[3]Vencovsky J, Machacek S, Sedova L, et al. Autoantibodies can be prognostic markers of an erosive disease in early rheumatoid arthritis[J]. Ann Rheum Dis,2003,62(5) :427 ～ 30.
2[6]Michele Bombardieri, Cristiano Alessandri, Giancario Labbadia et al. Role of anti-cyclic citrullinated peptide antibodies in discriminating patients with rheumatoid arthritis from patients with chronic hepatitis C infection - associated polyarticular involvement[J]. Arthritis Res Ther,2004,6(6): 137 ～ 41.
3Pincus T.Aggressive treatment of early rheumatoid arthritis to prevent joint damage[J].Bull Rheum Dis,1998,47(8):2-7.
4Menard HA,Lapointe E,Rochdi MA,et al.Insights into rheumatoid arthritis derived from rhe Sa immune system[J].Arthritis Res,2000,2(6):429-432.
5Schellekens GA,Visser H,de-Jong BA,et al.The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide[J].Arthritis Rheum,2000,43(1):155-163.
6Arnett FC,Eolworthy SM,Bloch DA,et al.The American rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis[J].Arthritis Rheum,1988,31(3):315-324.
7Schellekens GA,de-Jong BA,van-den-Hoogen FH,et al.Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies[J].J Clin Invest,1998,101(1):273-281.
5Kim SK, Bae J, Lee H, et al. Greater prevalence of seropositivity for anti-cyclic citrullinated peptide antibody in unaffected first-degree relatives in multicase rheumatoid arthritis-affected families[J]. Korean J Intern Med, 2013, 28(1) :45-53.
6Schellekens GA, Visser H, de Jong BA, et al. The diag- nostic properties of rheumatoid arthritis antibodies recog- nizing a cyclic citrullinated peptide[J]. Arthritis Rheum, 2000,43(1) : 155-163.
7Suzuki K, Sawada T, Murakami A, et al. High diagnostic performance of ELISA detection of antibodies to citrulli- nated antigens in rheumatoid arthritis[J]. Scand J Rheu- matol,2003,32(4) : 197-204.
8Schellekens GA, Visser H, De Jong BAW, et al. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic eitrullinated peptide[J]. Arthritis Rheum, 2000,43 (1) : 155-163.
9Nanke Y, Kotake S, Akama H, et al. Alkaline phosphatase in rheumatoid arthritis patients: possible contribution of bone-type ALP to the raised activities of ALP in rheumatoid arthritis pa- tients[J]. Clin Rheumatol,2002,2l(3) :198-202.
10Kamradt T,Schubert D. The role and clinical implications of G6PI in experimental models of rheumatoid arthritis[J]. Arthritis Res Ther,2005,7(1):20 -28.
